Ming-Jong Bair

发表

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients

Chia-Ying Chu, M. Bair, Chun-Han Cheng, 2022, Frontiers in Endocrinology.

Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic

Ming‐Lung Yu, C. Tai, M. Bair, 2023, Viruses.

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

Mei-Hsuan Lee, J. Kao, Chun-Jen Liu, 2021, Infectious Diseases and Therapy.

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Liver international : official journal of the International Association for the Study of the Liver.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2019, The Journal of infectious diseases.

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

T. Tseng, J. Kao, T. Su, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis

C. Hung, P. Cheng, Kuang-Chun Hu, 2023, The Kaohsiung journal of medical sciences.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of hepatology.

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals

J. Kao, Chia-Chi Wang, Han‐Chieh Lin, 2022, Viruses.

Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers.

Chia-Ying Chu, M. Bair, Chun-Han Cheng, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience

M. Bair, Wen-Chi Chen, W. Tsai, 2020, PloS one.

Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C.

Chia-Ying Chu, M. Bair, Chun-Han Cheng, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection

Ming‐Lung Yu, C. Dai, Jee-Fu Huang, 2018, PloS one.

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2023, Journal of clinical and translational hepatology.

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial

C. Shun, Jaw-Town Lin, Yi-Chia Lee, 2016, The American Journal of Gastroenterology.

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.

E. El-Omar, C. Shun, Jaw-Town Lin, 2022, The lancet. Gastroenterology & hepatology.

Toward population specific and personalized treatment of Helicobacter pylori infection

Wen-Lun Wang, Jaw-Town Lin, Han-Mo Chiu, 2018, Journal of Biomedical Science.

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.

E. El-Omar, Wen-Lun Wang, C. Shun, 2018, Gastroenterology.

Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials

Jaw-Town Lin, C. Chen, Ming-Shiang Wu, 2017, The Journal of antimicrobial chemotherapy.

Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection

C. Chou, M. Bair, Jyh-Ming Liou, 2016, Alimentary pharmacology & therapeutics.

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial

C. Shun, Jaw-Town Lin, Yi-Chia Lee, 2015, Gut.

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study

Hsiu‐Po Wang, Jaw-Town Lin, B. Sheu, 2015, PloS one.

Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.

Ming-Shiang Wu, Horng‐Yuan Wang, S. Shih, 2014, World journal of gastroenterology.

Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients

Sun-Chong Wang, Chien-Sheng Chen, M. Bair, 2014, The Kaohsiung journal of medical sciences.

Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy

M. Bair, Chung-Yu Chen, Yingting Wang, 2020, Medicina.

Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method

Hsiu-Hsi Chen, Deng-Chyang Wu, Yi-Chia Lee, 2023, Gut.

Osteopontin Expression in Squamous Cell Cancer of the Esophagus

Jang-Ming Lee, Ming-Tsang Wu, Deng-Chyang Wu, 2008, World Journal of Surgery.

Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection

M. Bair, Chun-Han Cheng, Huan-Lin Chen, 2018, PloS one.

Evaluating Prescription Pattern and Effectiveness of Antihypertensive Drugs in Non-Operated Aortic Dissection Patients

M. Bair, Chung-Yu Chen, C. Shen, 2023, Journal of clinical medicine.

Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation.

Ming-Shiang Wu, Ming‐Jen Chen, S. Shih, 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment

Jung-Chun Lin, Hsiu‐Po Wang, I. Wu, 2018, Medicine.

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan

W. Lei, M. Bair, Huan-Lin Chen, 2023, Medicine.

Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.

M. Vaezi, W. Lei, J. Hung, 2020, Clinics and research in hepatology and gastroenterology.

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

Ming‐Lung Yu, Shiu-Feng Huang, M. Yeh, 2021, Hepatology International.

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, Open forum infectious diseases.

Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study

Chung-Yu Chen, C. Shen, Ming-Jong Bair, 2023, Frontiers in pharmacology.

W. Lei, J. Hung, C. Yi, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Nutritional Influences on Age-Related Frailty

S. Shih, M. Bair, Huan-Lin Chen, 2016 .

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection

Deng-Chyang Wu, Chung-Jung Liu, I. Wu, 2015, BioMed research international.

Impact of sofosbuvir-based direct-acting antivirals on renal function in chronic hepatitis C patients with impaired renal function: a large cohort study from the nationwide HCV Registry Program (TACR).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.

E. El-Omar, C. Shun, Jaw-Town Lin, 2023, The lancet. Gastroenterology & hepatology.

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.

E. El-Omar, E. Chuang, Jaw-Town Lin, 2019, The Lancet. Infectious diseases.

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

E. El-Omar, C. Shun, Jaw-Town Lin, 2016, The Lancet.

Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan.

Ming‐Jen Chen, Horng‐Yuan Wang, S. Shih, 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan.

M. Bair, Suh-Ching Yang, Sien‐Sing Yang, 2011, World journal of gastroenterology.

Football Sign of Pneumoperitoneum

Huan-Lin Chen, I. Lin, Chia‐Hsien Wu, 2010 .

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial

Wen-Lun Wang, C. Shun, Jaw-Town Lin, 2018, The Journal of antimicrobial chemotherapy.

Systematic review with meta‐analysis: 10‐ or 14‐day sequential therapy vs. 14‐day triple therapy in the first line treatment of Helicobacter pylori infection

M. Bair, Jyh-Ming Liou, Y-C Lee, 2016, Alimentary pharmacology & therapeutics.

Socioeconomic status, personal habits, and prevalence of Helicobacter pylori infection in the inhabitants of Lanyu.

Ming‐Jen Chen, Horng‐Yuan Wang, S. Shih, 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings.

H. Zou, Ching-Hsiang Chen, M. Bair, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.